
Citigrap P 500mg/800mg Tablet
Marketer
Grapple Life Sciences Pvt Ltd
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citigrap P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets aid in stroke recovery and cognitive improvement. This medication safeguards brain cells from harm and facilitates their repair, potentially assisting in brain injury treatment. NeuroMend can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Complete the entire course, even if feeling better, and avoid abrupt discontinuation without consulting your physician, as this could exacerbate symptoms. Common, usually temporary side effects include restlessness, abdominal discomfort, anxiety, and low blood pressure. Consult your doctor if these persist or are concerning. Maintain adequate hydration due to potential diarrhea. Weight gain is possible; manage this through a healthy diet and regular exercise.
Uses of Citigrap P 500mg/800mg Tablet
Stroke Recovery and Rehabilitation
Major Benefits of Citigrap P 500mg/800mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citigrap P 500mg/800mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Citigrap P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citigrap P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Citigrap P 500mg/800mg Tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.
How Citigrap P 500mg/800mg Tablet works:
The combined medication Citigrap P (500mg/800mg) contains citicoline and piracetam. Citicoline acts as a neuroprotectant, fostering neuronal health, shielding against cellular damage, and enhancing cell viability. Piracetam, a GABA analogue, offers neuroprotection against hypoxia and modulates various ion channels within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Citigrap P 500mg/800mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citigrap P 500mg/800mg Tablet in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Citigrap P 500mg/800mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be impaired by Citigrap P 500mg/800mg Tablets, which can induce drowsiness and tremors. These side effects could negatively impact your ability to operate a vehicle.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Citigrap P 500mg/800mg tablets, as dosage modification may be necessary. Consultation with a physician is advised. Citigrap P 500mg/800mg tablets are contraindicated in individuals with severely compromised kidney function.
LiverSAFE IF PRESCRIBED
The use of Citigrap P 500mg/800mg tablets in patients with liver disease appears to pose minimal risk. Available evidence indicates that dose modification may not be necessary for this patient population. However, physician consultation is recommended.
What if you forget to take Citigrap P 500mg/800mg Tablet :
Should you forget a Citigrap P 500mg/800mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citigrap P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
